Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000173862 | SCV000225026 | benign | not specified | 2014-09-24 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000224353 | SCV000281566 | benign | not provided | 2015-05-14 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000173862 | SCV000312163 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001084232 | SCV000562823 | benign | Spastic paraplegia | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000173862 | SCV001475445 | benign | not specified | 2019-11-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000224353 | SCV001948169 | benign | not provided | 2019-03-21 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001847804 | SCV002105109 | benign | Hereditary spastic paraplegia | 2021-09-01 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000224353 | SCV005230847 | benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000224353 | SCV000802130 | benign | not provided | 2017-08-22 | no assertion criteria provided | clinical testing | |
Natera, |
RCV001274927 | SCV001459487 | benign | Charlevoix-Saguenay spastic ataxia | 2020-09-16 | no assertion criteria provided | clinical testing |